Related Experiment Video
Updated: May 16, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Neonatal abstinence syndrome clinical practice guidelines for Ontario
Kimberly Dow1, Alice Ordean, Jodie Murphy-Oikonen
1Queens University and Kingston General Hospital, Toronto. owk2@kgh.kari.net
Abstract:
Ontario's clinical practice guidelines for neonatal abstinence syndrome (NAS) provide evidence-informed recommendations that address the needs of substance using pregnant women and newborns at risk of NAS. NAS is a complex and multifaceted issue that is escalating along with rapidly rising opioid use in Ontario. Reducing the incidence and impact of NAS requires immediate action in order to improve the care of affected women and infants. This includes optimizing and standardizing treatment strategies, assessing and managing social risk, better monitoring of prescribing practices and facilitating the implementation of better treatment and prevention strategies as they become available. These clinical practice guidelines provide the framework to inform and support the development of a coordinated strategy to address this important issue and to promote safe and effective care.
More Related Videos
Related Concept Videos
CNS Depressants: Alcohol and Nicotine
Standards of Care II
Drug Abuse and Addiction: Pharmacological Phenomena
Standards of Care I
Pharmacokinetics in Pediatric Patients: Drug Excretion
Guidelines for Writing Outcome
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care evaluation by...

